<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-03-31 12:30:05Epidemiology Influenza A virus subtype H5N1 Medicine Animal virology Antivirals Transmission and infection of H5N1 Orthomyxoviridae Interferon Cytokine storm Influenza Cytokines Biology |
| PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for genoDocID: 1vlwz - View Document |
| IMPORTANT PLEASE READ PART III: CONSUMER INFORMATION INTRON A® interferon alfa-2b This leaflet is part III of a three-part "Product Monograph"DocID: 1uNBi - View Document |
| Evaluation of Interferon-gamma-Producing T CellsDocID: 1uFKZ - View Document |
| PRODUCT MONOGRAPH INTRON A® interferon alfa-2b Lyophilized Powder with Diluent: 10 million IU interferon alfa-2b/vialDocID: 1umTG - View Document |
| Data Sheet Recombinant Human Interferon-gamma (rh IFN-) Preclinical Grade - Order No.: µg)DocID: 1u1rK - View Document |